Literature DB >> 17076939

Rubella seroprofile of the Italian population: an 8-year comparison.

M C Rota1, A Bella, G Gabutti, C Giambi, A Filia, M Guido, A De Donno, P Crovari, M L Ciofi Degli Atti.   

Abstract

The objective of this study is to evaluate how increasing MMR infant vaccination coverage in recent years has modified the epidemiology of rubella in Italy. A cross-sectional population-based seroprevalence study of rubella antibodies was conducted on 3094 sera, in 2004, and results were compared with data obtained by the same method in 1996. The overall proportion of rubella-seropositive individuals was found to be significantly higher in 2004 with respect to 1996 (84.6% vs. 77.4%). However, an increase in seropositivity was observed only in the 1-19 years age groups. Recent increases in childhood MMR vaccination coverage, therefore, have not had an impact on seroprevalence in women of childbearing age, over 5% of whom remain susceptible to rubella. Preconception screening and postpartum vaccination of susceptible women are fundamental if the WHO target of less than one case of congenital rubella syndrome per 100,000 live births is to be attained.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17076939      PMCID: PMC2870616          DOI: 10.1017/S0950268806007400

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  11 in total

1.  Epidemiology of measles, mumps and rubella in Italy.

Authors:  G Gabutti; M C Rota; S Salmaso; B M Bruzzone; A Bella; P Crovari
Journal:  Epidemiol Infect       Date:  2002-12       Impact factor: 2.451

2.  Do changes in policy affect vaccine coverage levels? Results of a national study to evaluate childhood vaccination coverage and reasons for missed vaccination in Italy.

Authors:  M L Ciofi Degli Atti; Maria Cristina Rota; Antonino Bella; Stefania Salmaso
Journal:  Vaccine       Date:  2004-10-22       Impact factor: 3.641

3.  Infant immunization coverage in Italy: estimates by simultaneous EPI cluster surveys of regions. ICONA Study Group.

Authors:  S Salmaso; M C Rota; M L Ciofi Degli Atti; A E Tozzi; P Kreidl
Journal:  Bull World Health Organ       Date:  1999       Impact factor: 9.408

4.  Declining seroprevalence of rubella antibodies among young Israeli adults: a 12-year comparison.

Authors:  Michael Huerta; Nadav Davidovitch; Omer E Ankol; Yona Zaaide; Itamar Grotto; Ran D Balicer; Eli Zangvil
Journal:  Prev Med       Date:  2004-12       Impact factor: 4.018

5.  First cases of rubella infection during pregnancy detected by new reporting system in Italy.

Authors:  M Ciofi degli Atti; A Filia; R Verteramo; S Iannazzo; F Curtale; L Masini; M De Santis; M G Pompa
Journal:  Euro Surveill       Date:  2006-03-23

Review 6.  Increase in congenital rubella occurrence after immunisation in Greece: retrospective survey and systematic review.

Authors:  T Panagiotopoulos; I Antoniadou; E Valassi-Adam
Journal:  BMJ       Date:  1999-12-04

7.  Evaluation of the measles, mumps and rubella immunisation programme in Spain by using a sero-epidemiological survey.

Authors:  C Amela; I Pachón; F de Ory
Journal:  Eur J Epidemiol       Date:  2003       Impact factor: 8.082

8.  The seroepidemiology of rubella in western Europe.

Authors:  R G Pebody; W J Edmunds; M Conyn-van Spaendonck; P Olin; G Berbers; I Rebiere; H Lecoeur; P Crovari; I Davidkin; G Gabutti; E Gerike; C Giordano; L Hesketh; A M Plesner; M Raux; M C Rota; S Salmaso; A Tischer; M Valle; E Miller
Journal:  Epidemiol Infect       Date:  2000-10       Impact factor: 2.451

9.  Rubella in England, Scotland and Wales.

Authors:  P Tookey
Journal:  Euro Surveill       Date:  2004-04

10.  New features of rubella in Spain: the evidence of an outbreak.

Authors:  C Lemos; R Ramirez; M Ordobas; D H Guibert; J C Sanz; L Garcia; J F Martinez Navarro
Journal:  Euro Surveill       Date:  2004-04
View more
  10 in total

1.  A protein microarray immunoassay for the serological evaluation of the antibody response in vertically transmitted infections.

Authors:  A Ardizzoni; B Capuccini; M C Baschieri; C F Orsi; F Rumpianesi; S Peppoloni; C Cermelli; M Meacci; A Crisanti; P Steensgaard; E Blasi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-05-05       Impact factor: 3.267

2.  Attitude toward immunization and risk perception of measles, rubella, mumps, varicella, and pertussis in health care workers working in 6 hospitals of Florence, Italy 2011.

Authors:  Cristina Taddei; Vega Ceccherini; Giuditta Niccolai; Barbara Rita Porchia; Sara Boccalini; Miriam Levi; Emilia Tiscione; Maria Grazia Santini; Simonetta Baretti; Paolo Bonanni; Angela Bechini
Journal:  Hum Vaccin Immunother       Date:  2014-10-30       Impact factor: 3.452

3.  Further efforts in the achievement of congenital rubella syndrome/rubella elimination.

Authors:  Vanessa Cozza; Domenico Martinelli; Maria Giovanna Cappelli; Silvio Tafuri; Francesca Fortunato; Rosa Prato
Journal:  Hum Vaccin Immunother       Date:  2014-11-01       Impact factor: 3.452

4.  Serological cross-sectional studies on salmonella incidence in eight European countries: no correlation with incidence of reported cases.

Authors:  Gerhard Falkenhorst; Jacob Simonsen; Tina H Ceper; Wilfrid van Pelt; Henriette de Valk; Malgorzata Sadkowska-Todys; Lavinia Zota; Markku Kuusi; Cecilia Jernberg; Maria Cristina Rota; Yvonne Thp van Duynhoven; Peter Fm Teunis; Karen A Krogfelt; Kåre Mølbak
Journal:  BMC Public Health       Date:  2012-07-16       Impact factor: 3.295

5.  Voluntary termination of pregnancy: An opportunity for Measles, Mumps and Rubella vaccination in an Italian healthcare local unit.

Authors:  V Pettinicchio; V Santoro; C Vazzoler; P Magliocchetti; D Orsini; A Lancia; E Franco
Journal:  Hum Vaccin Immunother       Date:  2017-12-21       Impact factor: 3.452

Review 6.  Strategies for elimination of rubella in pregnancy and of congenital rubella syndrome in high and upper-middle income countries.

Authors:  E Terracciano; F Amadori; V Pettinicchio; L Zaratti; E Franco
Journal:  J Prev Med Hyg       Date:  2020-04-02

7.  Seroprevalence of Measles-, Mumps-, and Rubella-specific antibodies in the German adult population - cross-sectional analysis of the German Health Interview and Examination Survey for Adults (DEGS1).

Authors:  Nicole Friedrich; Christina Poethko-Müller; Ronny Kuhnert; Dorothea Matysiak-Klose; Judith Koch; Ole Wichmann; Sabine Santibanez; Annette Mankertz
Journal:  Lancet Reg Health Eur       Date:  2021-06-05

Review 8.  Rubella antibody screening during pregnancy in an urban area of Northern Italy.

Authors:  Massimo De Paschale; Maria Teresa Manco; Alessia Paganini; Carlo Agrappi; Paola Mirri; Gabriella Cucchi; Barbara Saccani; Alberto Flores D'Arcais; Pierangelo Clerici
Journal:  Infect Dis Rep       Date:  2012-02-22

9.  A cohort study of a tailored web intervention for preconception care.

Authors:  Eleonora Agricola; Elisabetta Pandolfi; Michaela V Gonfiantini; Francesco Gesualdo; Mariateresa Romano; Emanuela Carloni; Pierpaolo Mastroiacovo; Alberto E Tozzi
Journal:  BMC Med Inform Decis Mak       Date:  2014-04-15       Impact factor: 2.796

10.  Elimination of congenital rubella: a seroprevalence study of pregnant women and women of childbearing age in Italy.

Authors:  Serena Marchi; Simonetta Viviani; Emanuele Montomoli; Claudia Maria Trombetta
Journal:  Hum Vaccin Immunother       Date:  2019-11-26       Impact factor: 3.452

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.